Resistance to medicines for combating superbugs has considerably worsened during the pandemic, with deaths and infections from several serious pathogens increasing at least 15% during the first year of the crisis, according to a new report by the Centers for Disease Control and Prevention.
The increased rates for some infections, however, were much larger. For instance, there was 78% jump among those infected with Acinetobacter, a gram-negative bacteria; a 60% rise in a fungal disease known as Candida auris, and a 32% percent rise in infections from another gram-negative bacteria, called Enterobacterales. These infections and others are resistant to antibiotics and antifungal medicines.